These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 20800593

  • 1. Neuroprotection in glaucoma - Is there a future role?
    Baltmr A, Duggan J, Nizari S, Salt TE, Cordeiro MF.
    Exp Eye Res; 2010 Nov; 91(5):554-66. PubMed ID: 20800593
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma.
    Chan HC, Chang RC, Koon-Ching Ip A, Chiu K, Yuen WH, Zee SY, So KF.
    Exp Neurol; 2007 Jan; 203(1):269-73. PubMed ID: 17045262
    [Abstract] [Full Text] [Related]

  • 5. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W, Dorecka M, Romaniuk W.
    Klin Oczna; 2007 Jan; 109(7-9):349-52. PubMed ID: 18260296
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
    Hernández M, Urcola JH, Vecino E.
    Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotection in glaucoma: recent and future directions.
    Danesh-Meyer HV.
    Curr Opin Ophthalmol; 2011 Mar; 22(2):78-86. PubMed ID: 21252670
    [Abstract] [Full Text] [Related]

  • 9. The molecular basis of retinal ganglion cell death in glaucoma.
    Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A.
    Prog Retin Eye Res; 2012 Mar; 31(2):152-81. PubMed ID: 22155051
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia-induced retinal ganglion cell death and the neuroprotective effects of beta-adrenergic antagonists.
    Chen YN, Yamada H, Mao W, Matsuyama S, Aihara M, Araie M.
    Brain Res; 2007 May 07; 1148():28-37. PubMed ID: 17368577
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.
    Bai Y, Xu J, Brahimi F, Zhuo Y, Sarunic MV, Saragovi HU.
    Invest Ophthalmol Vis Sci; 2010 Sep 07; 51(9):4722-31. PubMed ID: 20357199
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
    Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML.
    Invest Ophthalmol Vis Sci; 2008 Apr 07; 49(4):1437-46. PubMed ID: 18385061
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. History of neuroprotection and rationale as a therapy for glaucoma.
    Levin LA, Peeples P.
    Am J Manag Care; 2008 Feb 07; 14(1 Suppl):S11-4. PubMed ID: 18284310
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relevance of the site of injury of glaucoma to neuroprotective strategies.
    Levin LA.
    Surv Ophthalmol; 2001 May 07; 45 Suppl 3():S243-9; discussion S273-6. PubMed ID: 11377443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.